News coverage about AptarGroup (NYSE:ATR) has trended positive recently, according to Accern. The research firm identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. AptarGroup earned a news sentiment score of 0.28 on Accern’s scale. Accern also assigned news stories about the industrial products company an impact score of 47.1593738649559 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
These are some of the media headlines that may have impacted Accern Sentiment’s analysis:
- Insider Selling: AptarGroup, Inc. (ATR) Director Sells 25,000 Shares of Stock (americanbankingnews.com)
- Eldon W. Schaffer II Sells 20,000 Shares of AptarGroup, Inc. (ATR) Stock (americanbankingnews.com)
- Analysts Issue Forecasts for AptarGroup, Inc.’s Q1 2018 Earnings (ATR) (americanbankingnews.com)
- AptarGroup, Inc. to Post Q1 2018 Earnings of $0.92 Per Share, William Blair Forecasts (ATR) (americanbankingnews.com)
- Robert W. Baird Reiterates Hold Rating for AptarGroup (ATR) (americanbankingnews.com)
ATR has been the subject of several recent research reports. Zacks Investment Research raised AptarGroup from a “hold” rating to a “buy” rating and set a $98.00 price target for the company in a report on Wednesday, January 31st. KeyCorp reaffirmed a “hold” rating on shares of AptarGroup in a report on Friday, October 27th. Wells Fargo & Co reiterated a “market perform” rating and issued a $90.00 price objective (up from $83.00) on shares of AptarGroup in a research report on Wednesday. Finally, Robert W. Baird reiterated a “hold” rating and issued a $92.00 price objective on shares of AptarGroup in a research report on Wednesday. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the company. AptarGroup presently has a consensus rating of “Hold” and a consensus price target of $85.38.
AptarGroup (NYSE:ATR) last issued its quarterly earnings data on Monday, February 12th. The industrial products company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.10. The company had revenue of $625.90 million during the quarter, compared to analyst estimates of $577.17 million. AptarGroup had a return on equity of 16.97% and a net margin of 8.91%. The firm’s revenue for the quarter was up 16.1% compared to the same quarter last year. During the same period in the prior year, the business posted $0.69 earnings per share. equities research analysts predict that AptarGroup will post 3.59 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 21st. Investors of record on Wednesday, January 31st will be given a $0.32 dividend. The ex-dividend date is Tuesday, January 30th. This represents a $1.28 annualized dividend and a yield of 1.40%. AptarGroup’s payout ratio is 37.54%.
In other news, Director Stephen J. Hagge sold 25,000 shares of the firm’s stock in a transaction on Thursday, February 15th. The stock was sold at an average price of $91.17, for a total transaction of $2,279,250.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Robert Kuhn sold 5,000 shares of the firm’s stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $87.43, for a total value of $437,150.00. The disclosure for this sale can be found here. Insiders sold 76,000 shares of company stock valued at $6,782,580 over the last quarter. 5.30% of the stock is currently owned by company insiders.
AptarGroup Company Profile
AptarGroup, Inc is a provider of a range of packaging, dispensing and sealing solutions, primarily for the beauty, personal care, homecare, prescription drug, consumer healthcare, injectables, food and beverage markets. The Company has manufacturing facilities located throughout the world, including North America, Europe, Asia and South America.
Receive News & Ratings for AptarGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup and related companies with MarketBeat.com's FREE daily email newsletter.